Log In
Print
BCIQ
Print
Print this Print this
 

Aerospan, flunisolide HFA

  Manage Alerts
Collapse Summary General Information
Company Actavis plc
DescriptionHydrofluoroalkane (HFA)-propelled inhaled formulation of flunisolide
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationAsthma
Indication DetailsTreat mild persistent asthma
Regulatory Designation

Partner

Meda AB


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today